AIMS Faridabad adopts cobas platform by Roche Diagnostics
26 June 2022 | News
Cobas solutions will enable the institute to further enhance testing in the realms of endocrinology, immunology, and metabolic diseases
Image credit: twitter
Asian Institute of Medical Science (AIMS) in Delhi NCR has installed Roche Diagnostics’ fully automated latest state-of-the-art technology- cobas pro e801 and cobas pure e402 to enhance healthcare delivery and patient experience. The technologies offer a wider assay menu including thyroid, fertility, cardiac, cancer, infectious, vitamins others.
Using the cobas solutions will enable the institute to further enhance testing in the realms of endocrinology, immunology, and metabolic diseases. These instruments can facilitate the smallest sample volume in the industry on immunology with a shorter Turnaround Time (TAT). Through automation, Roche Diagnostics’ new solutions are designed to simplify workflows and improve the productivity of lab personnel whilst also supporting the delivery of better patient care.
